Not exact matches
After preclinical studies, a
gene therapy trial for SCID - X1 was initiated, based on the use of complementary DNA containing a defective γc Moloney retrovirus — derived vector
and ex
vivo infection of CD34 +
cells.
Intellia is developing human
gene and cell therapies for both ex
vivo and in
vivo applications using CRISPR - Cas9
gene editing technology.
Fundamental Science Overview
Gene and gene - modified cell therapies treat diseases by delivering therapeutic DNA into a patient's cells, either in (in vivo) or outside his or her body (ex vi
Gene and gene - modified cell therapies treat diseases by delivering therapeutic DNA into a patient's cells, either in (in vivo) or outside his or her body (ex vi
gene - modified
cell therapies treat diseases by delivering therapeutic DNA into a patient's
cells, either in (in
vivo) or outside his or her body (ex
vivo).
Zonari E, Desantis G, Petrillo C, Boccalatte FE, Lidonnici MR, Kajaste - Rudnitski A, Aiuti A, Ferrari G, Naldini L, Gentner B. Efficient ex
vivo engineering
and expansion of highly purified human hematopoietic stem
and progenitor
cell populations for
gene therapy.